China Pharma Holdings (CPHI) Net Margin Growth (1y) (2011 - 2026)
China Pharma Holdings (CPHI) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.11 Bn | 43.15 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.24 Bn | 39.59 Bn | 2.15 Bn | -2,064.00 |
| 3 | Zoetis | 31.84 Bn | 30.17 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -195.00 |
| 5 | United Therapeutics | 22.44 Bn | 19.78 Bn | 683.80 Mn | 376.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -303.00 |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | -58.00 |
| 8 | Elanco Animal Health | 12.03 Bn | 11.50 Bn | 798.00 Mn | 306.00 |
| 9 | Dr Reddys Laboratories | 10.06 Bn | 9.89 Bn | - | - |
| 10 | China Pharma Holdings | 41.33 Mn | 41.03 Mn | 83,566.00 | -10,225.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,709.00 |
| Dec 31, 2025 | 829.00 |
| Sep 30, 2025 | 1,546.00 |
| Jun 30, 2025 | 10,397.00 |
| Mar 31, 2025 | 65.00 |
| Dec 31, 2024 | -5,065.00 |
| Sep 30, 2024 | -5,850.00 |
| Jun 30, 2024 | -10,147.00 |
| Mar 31, 2024 | -4,550.00 |
| Dec 31, 2023 | -1,404.00 |
| Sep 30, 2023 | -289.00 |
| Jun 30, 2023 | 106.00 |
| Mar 31, 2023 | 3,990.00 |
| Dec 31, 2022 | -934.00 |
| Sep 30, 2022 | 156.00 |
| Jun 30, 2022 | -2,093.00 |
| Mar 31, 2022 | -3,165.00 |
| Dec 31, 2021 | 731.00 |
| Sep 30, 2021 | 29.00 |
| Jun 30, 2021 | -3,449.00 |